FACTSET RESEARCH SYSTEMS INC (FDS)       427.56  -5.74 (-1.32%)

427.56  -5.74 (-1.32%)

US3030751057 - Common Stock - After market: 427.56 0 (0%)


Fundamental Rating

5

Taking everything into account, FDS scores 5 out of 10 in our fundamental rating. FDS was compared to 202 industry peers in the Capital Markets industry. While FDS has a great health rating, its profitability is only average at the moment. FDS is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

6

FDS has a Return On Assets of 10.71%. This is better than the industry average of 4.11%.
FDS has a Return On Equity of 28.90%. This is amongst the best returns in the industry. The industry average is 11.60%. FDS outperforms 86% of its industry peers.

FDS's Profit Margin of 22.15% is in line with the rest of the industry. The industry average Profit Margin is 20.52%.
FDS has a Piotroski-F score of 4.00. This indicates an average health and profitability for FDS.
VS Industry

ROA (10.71%) VS Industry: 80% outperformed.

0.03
49.12

ROE (28.9%) VS Industry: 86% outperformed.

0.18
291.37

Profit Margin (22.15%) VS Industry: 55% outperformed.

0.30
84,632.11

Valuation

Valuation Rating

0

When comparing the current price to the book value of FDS, we can conclude it is valued correctly. It is trading at 11.09 times its book value.
With a Price/Earnings Ratio of 30.22, FDS can be considered very expensive at the moment.
With a Price/Earning Ratio of 30.22, FDS is valued a higher than the industry average, which is at 11.71. 89% of the companies listed in the same industry are cheaper than FDS!
With a Forward Price/Earnings Ratio of 25.84, FDS is valued very expensively.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
Compared to an average industry price book ratio of 1.22, FDS is valued more expensive than its industry peers. 97% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 12.42, FDS is valued more expensive than its industry peers. 86% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (30.22) VS Industry: 11% outperformed.

267.00
0.93

Price/Book (11.09) VS Industry: 3% outperformed.

76.05
0.15

Enterprise Value/ EBITDA (26.11) VS Industry: 14% outperformed.

167.95
0.71

Growth

Growth Rating

5

The Earnings Per Share has grown by an impressive 25.00% over the past year.
The Earnings Per Share has been growing by 12.90% on average over the past 5 years. This is quite good.
Looking at the last year, FDS shows a quite strong growth in Revenue. The Revenue has grown by 18.18% in the last year.
The Earnings Per Share is expected to grow by 9.39% on average over the next 5 years.

Measured over the past 5 years, FDS shows a small growth in Revenue. The Revenue has been growing by 8.59% on average per year.
The Revenue is expected to grow by 8.10% on average over the next 5 years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS12.9% 10.27% 25% 11.38% 11.07% 10.73% 9.39%
Revenue8.59% 8.71% 18.18% 14.82% 10.85% 9.28% 8.1%

Health

Health Rating

7

A Current Ratio of 2.16 indicates that FDS has no problem at all paying its short term obligations.
FDS is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.33.
A Quick Ratio of 2.16 indicates that FDS has no problem at all paying its short term obligations.
The Quick Ratio of FDS is much better than the industry average of 1.30.

An Altman-Z score of 5.47 indicates that FDS is not in any danger for bankruptcy at the moment.
The Altman-Z score of FDS is much better than the industry average of 1.06. FDS has a better rating than 85% of its industry peers.
FDS has a Piotroski-F score of 4.00. This indicates an average health and profitability for FDS.
Compared to an average industry Debt to Equity Ratio of 0.61, FDS is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (1.26) VS Industry: 25% outperformed.

8.26
0.00

Quick Ratio (2.16) VS Industry: 69% outperformed.

0.01
5,803.88

Current Ratio (2.16) VS Industry: 69% outperformed.

0.01
5,803.88

Altman-Z (5.47) VS Industry: 85% outperformed.

-99.05
5,571.83

Dividend

Dividend Rating

5

The dividend of FDS is nicely growing with an annual growth rate of 7.93%!
FDS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
FDS pays out 30.26% of its income as dividend. This is a sustainable payout ratio.
FDS has been paying a dividend for at least 10 years, so it has a reliable track record.

FDS has a yearly dividend return of 0.84%, which is pretty low.
With a Dividend Yield of 0.84, FDS pays less dividend than the industry average, which is at 5.06. 93% of the companies listed in the same industry pay a better dividend than FDS!
Compared to an average S&P500 Dividend Yield of 2.41, FDS's dividend is way lower than the S&P500 average.
VS Industry

Dividend Yield (0.84%) VS Industry: 7% outperformed.

0.02
168.27

FACTSET RESEARCH SYSTEMS INC427.56

NYSE:FDS (2/3/2023, 7:04:00 PM)-5.74 (-1.32%)

After market: 427.56 0 (0%)

Chartmill FA Rating
GICS Sector Financials
GICS IndustryGroup Diversified Financials
GICS Industry Capital Markets
Earnings (Last) 12-20 2022-12-20/bmo Earnings (Next) 03-22 2023-03-22/amc
Inst Owners 87.17% Inst Owner Change -0.49%
Ins Owners 0.11% Ins Owner Change 37.72%
Market Cap 16.35B Analysts 65.71
Price Target 451.12 (5.51%)

Dividend
Industry RankSector Rank
Dividend Yield 0.84%
Dividend Growth(5Y) 7.93% DP 30.26%
Div Incr Years 17 Div Non Decr Years 17
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) 3.11%
Min EPS beat(2) -3.27% Max EPS beat(2) 9.49%
EPS beat(4) 3 Avg EPS beat(4) 7.57%
Min EPS beat(4) -3.27% Max EPS beat(4) 15.22%
Revenue beat(2) 1 Avg Revenue beat(2) -0.28%
Min Revenue beat(2) -2.03% Max Revenue beat(2) 1.47%
Revenue beat(4) 3 Avg Revenue beat(4) 0.26%
Min Revenue beat(4) -2.03% Max Revenue beat(4) 1.47%
PT rev (1m) 0.31% PT rev (3m) 3.53%
EPS NQ rev (1m) 0.69% EPS NQ rev (3m) 0.8%
EPS NY rev (1m) 0% EPS NY rev (3m) 0.01%
Revenue NQ rev (1m) -0.56% Revenue NQ rev (3m) -0.56%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -0.02%

Valuation
Industry RankSector Rank
PE 30.22
Fwd PE 25.84
P/S 8.5
P/FCF 31.98
P/OCF 28.59
P/B 11.09
P/tB N/A
EV/EBITDA 26.11
EPS(TTM) 14.15 EY 3.31%
EPS(NY) 16.54 Fwd EY 3.87%
FCF(TTM) 13.37 FCFY 3.13%
OCF(TTM) 14.95 OCFY 3.5%
SpS 50.3 BVpS 38.54
TBVpS -36.17 PEG (NY) 2.65
PEG (5Y) 2.34

Profitability
Industry RankSector Rank
ROA 10.71%
ROE 28.9%
ROIC 14.24%
ROICexc 16.38%
ROICexgc 192.37%
OM 30.4%
PM 22.15%
GM 53.69%
ROICexgc(3y) 168.8% ROICexcg growth 3Y 1.15%
ROICexcg growth 5Y -2.37% ROICexc(3y) 27.44%
ROICexc growth 3Y -27.1% ROICexc growth 5Y -13.25%
OM growth 3Y -1.38% OM growth 5Y 0.08%
PM growth 3Y -4.32% PM growth 5Y 0.35%
GM growth 3Y 7.39% GM growth 5Y 4.44%
F-Score 4 Asset Turnover 0.48

Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 3.63
Debt/EBITDA 2.74
Cap/Depr 64.92%
Profit Quality 120.04%
Current Ratio 2.16
Quick Ratio 2.16
Altman-Z 5.47
F-Score 4 WACC N/A
ROIC/WACC N/A Cap/Depr(3y) 96.28%
Cap/Depr(5y) 89.1% Profit Quality(3y) 120.39%
Profit Quality(5y) 119.45%

Growth
EPS 1Y 25% EPS 3Y 10.27%
EPS 5Y 12.9% EPS growth Q2Q 22.77%
EPS Next Y 11.38% EPS Next 2Y 11.07%
EPS Next 3Y 10.73% EPS Next 5Y 9.39%
Revenue growth 1Y 18.18% Revenue growth 3Y 8.71%
Revenue growth 5Y 8.59% Revenue growth Q2Q 18.86%
Revenue Next Year 14.82% Revenue Next 2Y 10.85%
Revenue Next 3Y 9.28% Revenue Next 5Y 8.1%
EBIT growth 1Y 22.04% EBIT growth 3Y 7.21%
EBIT growth 5Y 8.68% EBIT Next Year 28.97%
EBIT Next 3Y 13.88% EBIT Next 5Y 11.24%
FCF growth 1Y 18.89% FCF growth 3Y 9.83%
FCF growth 5Y 11.43% OCF growth 1Y 14.56%
OCF growth 3Y 8.02% OCF growth 5Y 10.93%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA